Skip to main content
. 2023 Jun 23;17:1205489. doi: 10.3389/fnins.2023.1205489

Table 1.

Demographic, clinical and descriptive MRI analyses of the total cohort, stratified between NP/Non-ASD and autism cases.

Patients Total cohort (n = 136) NP/Non-ASD (n = 72) ASD (n = 64) p
Median (IQR) age, years 4 (2–6) 4 (2–7) 3 (2–5) 0.06
Females, n (%) 53 (39.0) 32 (44.4) 21 (32.8) 0.17
Complex autism (%) 54 (84.4)
ASD Severity n (%) Mild 1 10 (15.6)
Moderate 2 18 (28.1)
Severe 3 36 (56.3)
IQ levels n (%) Normal 19 (37.3) 11 (52.4) 8 (26.7) 0.34
Borderline 16 (31.4) 6 (28.6) 10 (33.3)
Mild 7 (13.7) 1 (4.8) 6 (20.0)
Moderate 6 (11.8) 2 (9.5) 4 (13.3)
Severe 3 (5.9) 1 (4.8) 2 (6.7)
ADHD, n (%) 13 (9.6) 3 (4.2) 10 (15.6) 0.04
Sleep disorders, n (%) 24 (17.7) 0 (0.0) 24 (37.5) <0.0001
Epilepsy, n (%) 17 (12.5) 8 (11.1) 9 (14.1) 0.60
MRI findings
PVS enlargement, n (%) 7 (5.1) 3 (4.2) 4 (6.3) 0.71
Abnormal size of CSF spaces, n (%)* 17 (12.5) 13 (18.1) 4 (6.3) 0.04
Gliosis, n (%) 27 (19.9) 14 (19.4) 13 (20.3) 0.90
Malformation, n (%)** 11 (8.1) 8 (11.1) 3 (4.7) 0.22
Normal, n (%) 62 (45.6) 31 (43.1) 31 (48.4) 0.53
Median (IQR) WM-PVS volume (n. of voxel) 545 (334.5–902.5) 532.5 (312.0–735.5) 621.5 (374–1,061) 0.07
WM-PVS grade, n (%) 1 (1–10) 6 (4.4) 5 (6.9) 1 (1.6) 0.10
2 (11–20) 32 (23.5) 15 (20.8) 17 (26.6)
3 (21–40) 57 (41.9) 35 (48.6) 22 (34.4)
4 (>40) 41 (30.2) 17 (23.6) 24 (37.5)

*Benign enlargement or restriction of ventricular size; benign enlargement of subarachnoid space; idiopathic aqueduct stenosis, megacisterna magna, Chiari I with or without syringomyelia. **Macrocephaly, microcephaly, cerebellar atrophy, abnormal septum pellucidum, abnormal corpus callosum, abnormal neuronal migration, abnormal cortical organization. Significant p values are in bold.